Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs

Aprecia Pharmaceuticals announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology.
a year ago

3DP Technology and life-saving drugs combine to deliver significant quality-of-life benefits for rare disease patients

13 December 2017 - CINCINNATI & CAMBRIDGE, England--(BUSINESS WIRE)

Aprecia Pharmaceuticals, The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration.

Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s ZipDose®3DP technology can formulate fast-melt pharmaceutical products, incorporating significantly higher amounts of active pharmaceutical ingredient than any other fast-melt technology on the market. As such, this advanced technology can uniquely overcome both pill burden and dysphagia – swallowing difficulties, both of which are life-long, daily issues for so many rare disease patients.”

“We are excited to work with the Cycle team, and we see important synergies in the companies’ shared mission to address unmet needs in patient care,” said Don Wetherhold, CEO of Aprecia. “Cycle specializes in orphan drugs - they have proven that they can deliver quality-of-life improvements to rare disease patients around the world. Aprecia is fully committed to applying its ZipDose® 3DP printing technology to address real-world, daily issues faced by rare disease patients,” he continued.

Source: Aprecia Pharmaceuticals, LLC

Illustration Photo: Drugs (CC0 Creative Commons from Pixabay.com)

Comments

No comments to display.

Related posts

EU Call for Proposals: Multi-use of the marine space, offshore and near-shore: pilot demonstrators

Activities shall develop pilots by involving industrial actors and by integrating the available knowledge, technologies and facilities, in particular capitalising on the results of EU and national projects for the development of multi-use platforms or co-location of different activities in a marine space, and relevant support offshore vessels and autonomous vehicles.
Application Deadline in 2 days
16 hours ago

EU Call for Proposals: The Future of Seas and Oceans Flagship Initiative

Proposals shall address one of the following sub-topics: blue cloud services, or ocean observations and forecasting, or technologies for observations (in 2020). Actions shall demonstrate integration, capacity and (scientific, economic etc) potential.
Application Deadline in 2 days
16 hours ago

EU's Call for Proposals: Modelling international trade in agri-food products

Trade modelling has a long-standing tradition but some issues are notoriously difficult to assess and include in the existing simulation models.
Application Deadline in 2 days

EU Call for Proposals: Circular bio-based business models for rural communities

Based on an established agro-food system, proposals shall consider a variety of additional bio-based processes and end products that could be integrated into the system, and that are viable on a small scale (farm to rural community level).
Application Deadline in 2 days
16 hours ago

The Infant Formula Testing Market is expected grow at a CAGR of 6.9% to reach revenue of $20.26billion by 2023.

Infant formula is one of the emerging markets in food and beverage industry. It is basically used for the infants whose age is below 12 months (preferably).

UNICEF Innovation Fund's Call for Applications: Data science, machine learning, artificial intelligence or similar technology solutions

The UNICEF Innovation Fund is looking to make up to 100K equity-free investments to provide early stage (seed) finance to for-profit technology start-ups that have the potential to benefit humanity. If you’ve got a start-up registered in one of UNICEF’s programme countries and have a working, open source prototype (or you are willing to make it open-source) showing promising results, the UNICEF Innovation Fund is looking for you.
Application Deadline in a month

Etisalat Digital accelerates adoption of Artificial Intelligence and Blockchain in the United Arab Emirates

Etisalat Digital selects four disruptive companies to join Future Now scaleup programme after Dubai Future Accelerators collaboration.

European Venture Investment Reaches All-Time High

Europe's venture capital investment eclipsed €20 billion for the first time ever, according to PitchBook's 4Q 2018 European Venture Report. Despite the 25.9% drop in deal volume year-over-year (YoY), swelling deal sizes and increased interest from nontraditional investors helped drive deal value to the high-water mark.

The African Union Ten Years Aquaculture Action Plan for Africa 2016 - 2025

The prospects for Africa’s aquaculture are enormous. They are defned by the continent’s vast aquatic resources, land mass and climate that are suitable for the production of an array fsh species and essential inputs such as ingredients for feed. Of added advantage, is the fact that most of the world’s important tropical and sub-tropical aquaculture species are native to Africa.

Singapore-based SEEDS Capital appoints seven partners to co-invest in agrifood tech startups

SEEDS Capital, the investment arm of Enterprise Singapore, has appointed seven co-investment partners under Startup SG Equity. This will catalyse more than S$90 million worth of investments to develop Singapore-based startups in the Agrifood tech sector. This was announced by Senior Minister of State for Trade and Industry, Dr Koh Poh Koon, at the opening of Indoor Ag-Con Asia.